Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues - PubMed (original) (raw)
Comparative Study
Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues
Almoutassem B Zetoune et al. BMC Genet. 2008.
Abstract
Background: The Nonsense-Mediated mRNA Decay (NMD) pathway detects and degrades mRNAs containing premature termination codons, thereby preventing the accumulation of potentially detrimental truncated proteins. Intertissue variation in the efficiency of this mechanism has been suggested, which could have important implications for the understanding of genotype-phenotype correlations in various genetic disorders. However, compelling evidence in favour of this hypothesis is lacking. Here, we have explored this question by measuring the ratio of mutant versus wild-type Men1 transcripts in thirteen tissues from mice carrying a heterozygous truncating mutation in the ubiquitously expressed Men1 gene.
Results: Significant differences were found between two groups of tissues. The first group, which includes testis, ovary, brain and heart, displays a strong decrease of the nonsense transcript (average ratio of 18% of mutant versus wild-type Men1 transcripts, identical to the value measured in murine embryonic fibroblasts). The second group, comprising lung, intestine and thymus, shows much less pronounced NMD (average ratio of 35%). Importantly, the extent of degradation by NMD does not correlate with the expression level of eleven genes encoding proteins involved in NMD or with the expression level of the Men1 gene.
Conclusion: Mouse models are an attractive option to evaluate the efficiency of NMD in multiple mammalian tissues and organs, given that it is much easier to obtain these from a mouse than from a single individual carrying a germline truncating mutation. In this study, we have uncovered in the thirteen different murine tissues that we examined up to a two-fold difference in NMD efficiency.
Figures
Figure 1
Description of the Men1 mouse model used in the analysis. (a) Schematic representation of the mutant and of the wild-type allele of the Men1 gene in the heterozygous Men1 mutant mice. Black boxes and lines represent exons and introns respectively. The grey horizontal arrow depicts a loxP sequence, and the black vertical arrow shows the location of the premature stop codon generated by exon 3 deletion. The strategy used to delete Men1 exon 3 in mice has been described previously [17]. (b) Transcript copy number were measured by quantitative RT-PCR using 50 pg of RNA extracted from Men1+/Δ mouse embryonic fibroblasts (MEF) untreated or treated with puromycin (Puro). Specific amplification of either the wild-type (WT) or the mutant (Mu) transcript lacking exon 3 was achieved using the primers described in the Methods section.
Figure 2
NMD efficiency in 13 tissues of mice heterozygous for a truncating mutation in the Men1 gene. NMD efficiency is expressed as a ratio of the amount of mutant Men1 transcripts versus wild-type species, as measured by quantitative RT-PCR. Each bar on the graph represents the mean value of at least 3 independent measurements (± standard deviation) in four samples of the same tissue (two samples only were used for testis and ovary).
Figure 3
Men1 transcript levels in 13 murine tissues. Transcript levels (copy number per 50 pg of RNA extracted from each of the mentioned tissue) were measured by quantitative RT-PCR, and normalized to the level of Hprt1 and _β_-actin transcripts. Each bar on the graph represents the mean value of 3 independent measurements (± standard deviation) in four samples of the same tissue (two samples only were used for testis and ovary).
Figure 4
Transcript levels of the Upf1-3 and Smg1 genes in 13 murine tissues. Transcript levels (copy number per 50 pg of RNA extracted from each of the mentioned tissues) were measured by quantitative RT-PCR using the same samples as previously, and normalized to the level of Hprt1 and _β_-actin transcripts. Each bar on the graph represents the mean value of at least 3 independent measurements (± standard deviation) in four samples of the same tissue (two samples only were used for testis and ovary). Please note that the scale showing the normalized number of transcripts is different for each gene. Ov: ovary; Te: testis; Br: brain; He; heart; St; stomach; Ad: adrenal gland; Li: liver; Sp: spleen; M.G.: mammary gland; Ki: kidney; Lu: lung; In: intestine; Th: thymus.
Figure 5
Transcript levels of the genes encoding the EJC core proteins in 13 murine tissues. Transcript levels (copy number per 50 pg of RNA extracted from each of the mentioned tissues) were measured by quantitative RT-PCR using the same samples as previously, and normalized to the level of Hprt1 and _β_-actin transcripts, as in Figure 4.
Figure 6
Transcript levels of the genes encoding two splicing factors involved in the NMD mechanism in 13 murine tissues. Transcript levels (copy number per 50 pg of RNA extracted from each of the mentioned tissues) were measured by quantitative RT-PCR using the same samples as previously, and normalized to the level of Hprt1 and _β_-actin transcripts, as in Figure 4.
Similar articles
- Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species.
Conti E, Izaurralde E. Conti E, et al. Curr Opin Cell Biol. 2005 Jun;17(3):316-25. doi: 10.1016/j.ceb.2005.04.005. Curr Opin Cell Biol. 2005. PMID: 15901503 Review. - A system for coordinated analysis of translational readthrough and nonsense-mediated mRNA decay.
Baker SL, Hogg JR. Baker SL, et al. PLoS One. 2017 Mar 21;12(3):e0173980. doi: 10.1371/journal.pone.0173980. eCollection 2017. PLoS One. 2017. PMID: 28323884 Free PMC article. - Incomplete nonsense-mediated mRNA decay in Giardia lamblia.
Chen YH, Su LH, Sun CH. Chen YH, et al. Int J Parasitol. 2008 Sep;38(11):1305-17. doi: 10.1016/j.ijpara.2008.02.006. Epub 2008 Mar 21. Int J Parasitol. 2008. PMID: 18430426 - Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Linde L, Boelz S, Nissim-Rafinia M, Oren YS, Wilschanski M, Yaacov Y, Virgilis D, Neu-Yilik G, Kulozik AE, Kerem E, Kerem B. Linde L, et al. J Clin Invest. 2007 Mar;117(3):683-92. doi: 10.1172/JCI28523. Epub 2007 Feb 8. J Clin Invest. 2007. PMID: 17290305 Free PMC article. - The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?
Silva AL, Romão L. Silva AL, et al. FEBS Lett. 2009 Feb 4;583(3):499-505. doi: 10.1016/j.febslet.2008.12.058. Epub 2009 Jan 20. FEBS Lett. 2009. PMID: 19162024 Review.
Cited by
- The ribosome profiling landscape of yeast reveals a high diversity in pervasive translation.
Papadopoulos C, Arbes H, Cornu D, Chevrollier N, Blanchet S, Roginski P, Rabier C, Atia S, Lespinet O, Namy O, Lopes A. Papadopoulos C, et al. Genome Biol. 2024 Oct 14;25(1):268. doi: 10.1186/s13059-024-03403-7. Genome Biol. 2024. PMID: 39402662 Free PMC article. - Monoallelic de novo AJAP1 loss-of-function variants disrupt trans-synaptic control of neurotransmitter release.
Früh S, Boudkkazi S, Koppensteiner P, Sereikaite V, Chen LY, Fernandez-Fernandez D, Rem PD, Ulrich D, Schwenk J, Chen Z, Le Monnier E, Fritzius T, Innocenti SM, Besseyrias V, Trovò L, Stawarski M, Argilli E, Sherr EH, van Bon B, Kamsteeg EJ, Iascone M, Pilotta A, Cutrì MR, Azamian MS, Hernández-García A, Lalani SR, Rosenfeld JA, Zhao X, Vogel TP, Ona H, Scott DA, Scheiffele P, Strømgaard K, Tafti M, Gassmann M, Fakler B, Shigemoto R, Bettler B. Früh S, et al. Sci Adv. 2024 Jul 12;10(28):eadk5462. doi: 10.1126/sciadv.adk5462. Epub 2024 Jul 10. Sci Adv. 2024. PMID: 38985877 Free PMC article. - Physiological Consequences of Nonsense-Mediated Decay and Its Role in Adaptive Responses.
Ma Z, Sharma R, Rogers AN. Ma Z, et al. Biomedicines. 2024 May 16;12(5):1110. doi: 10.3390/biomedicines12051110. Biomedicines. 2024. PMID: 38791071 Free PMC article. Review. - Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects.
Karimi E, Gohlke J, van der Borgh M, Lindqvist J, Hourani Z, Kolb J, Cossette S, Lawlor MW, Ottenheijm C, Granzier H. Karimi E, et al. Acta Neuropathol. 2024 Apr 18;147(1):72. doi: 10.1007/s00401-024-02726-w. Acta Neuropathol. 2024. PMID: 38634969 Free PMC article. - Systematic analysis of nonsense variants uncovers peptide release rate as a novel modifier of nonsense-mediated mRNA decay efficiency.
Kolakada D, Fu R, Biziaev N, Shuvalov A, Lore M, Campbell AE, Cortázar MA, Sajek MP, Hesselberth JR, Mukherjee N, Alkalaeva E, Jagannathan S. Kolakada D, et al. bioRxiv [Preprint]. 2024 Apr 23:2024.01.10.575080. doi: 10.1101/2024.01.10.575080. bioRxiv. 2024. PMID: 38260612 Free PMC article. Preprint.
References
- Tournier I, Raux G, Di Fiore F, Marechal I, Leclerc C, Martin C, Wang Q, Buisine MP, Stoppa-Lyonnet D, Olschwang S, et al. Analysis of the allele-specific expression of the mismatch repair gene MLH1 using a simple DHPLC-Based Method. Hum Mutat. 2004;23:379–384. doi: 10.1002/humu.20008. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources